Evaluation of Blood/Imaging Based Biomarkers, Aromatase Inhibitor Induced Musculoskeletal Syndrome
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Aromatase Inhibitor Induced Musculoskeletal Syndrome (AIMSS)|Breast Cancer
Interventions: DIAGNOSTIC_TEST: Initial blood draw|DIAGNOSTIC_TEST: Initial SWE ultrasound|DIAGNOSTIC_TEST: Blood draw at three months|DIAGNOSTIC_TEST: Blood draw at six months|DIAGNOSTIC_TEST: SWE ultrasound at six months
Sponsor: University of Arizona